ETHE1 and hepatocellular carcinoma: In hepatocellular carcinoma (HCC), ETHE1 is overexpressed [50], where it is associated with inhibition of caspase 9 activation, suppressing DNA-damage induced apoptosis by binding to the RelA p65 subunit of NFkB, and increasing its export from the nucleus [50].